SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).
VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug This is the second Vanda drug to be approved in the span of a few months, after the approval of Nereus in December.
ImmunityBio Inks Partnerships To Launch Cancer Drug In Saudi Arabia Amid Expansion Efforts ImmunityBio announced that it has partnered with Biopharma and Cigalah and hopes to launch Anktiva across the broader Middle East and North Africa (MENA) region over time.
Lucid Reportedly Lays Off 12% Workforce Amid Gravity SUV Ramp-Up Techcrunch reported on Friday, citing an internal memo, that the layoffs are likely to impact hundreds of employees.
GE Stock On Track To Hit All-Time High: Morgan Stanley Calls It A ‘Structural Winner’, Flags 27% Upside Morgan Stanley initiated coverage of the stock with an ‘Overweight’ rating and a price target of $425, according to The Fly.
Trevian Wealth Management Buys $2.7 Million of Fidelity Nasdaq Composite Index ETF Fidelity Nasdaq Composite Index ETF tracks thousands of U.S.-listed growth and technology stocks for broad market exposure.
JNJ Stock Rises As Drugmaker Reportedly Eyes Orthopedics Segment Sale For Up To $20B Bloomberg reported, citing people familiar with the matter, that DePuy Synthes could be valued at more than $20 billion in a sale.
BKNG Stock Falls To Over 16-Month Lows – Brokerages Flag AI-Related Uncertainties Multiple brokerages, including Barclays and Oppenheimer, slashed their price targets despite a better-than-expected fourth quarter print.
This Heavily Sold Nano-Cap Skincare Stock Jumped 12% Pre-Market – What Happened? PMGC's unit, NorthStrive Biosciences, filed 10 new U.S. patent applications for EL-22 and EL-32 technologies in the animal health and agriculture markets.
CVNA Stock Slumps 10% Pre-Market: Wall Street Questions 2026 Visibility, Retail Flags ‘Deterioration’ Multiple brokerages slashed Carvana’s price target after the company’s fourth-quarter earnings fell below Street estimates.
Amazon Pips Walmart To Become World’s Biggest Company By Revenue Amazon reported revenue of $716.9 billion in the fiscal year 2025, while its retail rival Walmart posted $713.2 billion in revenue during the year.
Hims & Hers Health Makes Australia, Japan Foray With $1.15 Billion Eucalyptus Acquisition Hims & Hers Health, Inc. (HIMS) announced on Thursday that it has signed a definitive agreement to acquire Eucalyptus in a deal valued at up to $1.15 billion.
Qualcomm CEO Thinks India Could Be A Foundry Destination, Calls For Diversified Semiconductor Supply Chain: Report Qualcomm’s Cristiano Amon said that outside of the U.S., one of the company's largest research and development sites is in India.
Tesla Customers Drive Over 8B Miles With FSD, Still Trailing Waymo Driver In Autonomy Despite Bigger Fleet Tesla said that its vehicles with FSD traveled 5.3 million miles before a major collision, compared to a U.S. average of 660,000 miles.
Carvana Dismisses Short Seller Allegations As Misleading: Retailer’s Q4 Earnings Disappoint Wall Street Carvana said in a statement that the report by Hindenburg included “inaccurate, incomplete, and otherwise misleading information.”
Wingstop Shares Close Higher On Q4 Earnings Beat — Analyst Flags ‘Too Optimistic’ Guidance TD Cowen flagged that underlying challenges persist for Wingstop despite its Q4 results, according to TheFly.
What’s Sending SNAP Shares Up Today? The social media company said that its direct revenue segment had exceeded a $1 billion annualized revenue run rate, and its global subscription community has crossed 25 million members.
IBRX Gains 30% On Fresh Approval For Bladder Cancer Drug In EU: Retail, Wall Street Eyes Further Rally The European Commission granted conditional marketing authorization to ImmunityBio’s Anktiva, implying that it wants more data from the company.
Google Launches Its Latest Affordable Phone At $499 The Pixel 10a is part of the company’s A-series that brings many of Google’s AI tools at a more affordable price point compared to the Pixel 10 series.
